Tarlatamab, a First-in-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small-Cell Lung Cancer: an Open-Label, Phase I Study
Luis Paz-Ares,Stephane Champiat,W. Victoria Lai,Hiroki Izumi,Ramaswamy Govindan,Michael Boyer,Horst-Dieter Hummel,Hossein Borghaei,Melissa L. Johnson,Neeltje Steeghs,Fiona Blackhall,Afshin Dowlati,Noemi Reguart,Tatsuya Yoshida,Kai He,Shirish M. Gadgeel,Enriqueta Felip,Yiran Zhang, Amrita Pati,Mukul Minocha,Sujoy Mukherjee,Amanda Goldrick,Dirk Nagorsen,Nooshin Hashemi Sadraei,Taofeek K. Owonikoko JOURNAL OF CLINICAL ONCOLOGY（2023）
关键词
Small-Cell Lung Cancer
AI 理解论文
溯源树
样例
